TickerFacts.

Compare

Stoke Therapeutics, Inc. vs Maravai Lifesciences Holdings, Inc. vs Lifevantage Corp vs Rhythm Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearStoke Therapeutics, Inc.
STOK		Maravai Lifesciences Holdings, Inc.
MRVI		Lifevantage Corp
LFVN		Rhythm Pharmaceuticals, Inc.
RYTM
Year ended2025-12-312025-12-312026-06-302025-12-31
Revenue$184.42M$185.74M$182.59M$189.76M
Revenue growth (YoY)+404.5%-28.3%-20.1%+45.8%
Gross marginn/a18.3%77.6%89.7% (computed)
Operating margin-11.2%-115.9%3.3%-101.2%
Net margin-3.7%-70.4%2.8%-103.6%
Net income-$6.88M-$130.77M$5.07M-$196.54M
EPS (Diluted)-$0.12-$0.90$0.40-$3.11
Operating cash flow$45.59M-$57.57M$10.24M-$115.67M
Free cash flow$44.91M-$70.72M$6.67M-$116.63M
Cash & equivalents$84.22M$216.89Mn/a$54.30M
Total assets$418.43M$770.58M$62.11M$480.20M
Total liabilities$65.98M$397.87M$28.52M$210.17M
Shareholders' equity$352.46M$212.38M$33.59M$139.07M
Return on year-end equity-2.0%-61.6%15.1%-141.3%
Shares outstanding58.92Mn/a12.52M67.21M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearStoke Therapeutics, Inc.Maravai Lifesciences Holdings, Inc.Lifevantage CorpRhythm Pharmaceuticals, Inc.
Latest$184.42M
Ended 2025-12-31		$185.74M
Ended 2025-12-31		$182.59M
Ended 2026-06-30		$189.76M
Ended 2025-12-31
1 year earlier$36.55M
Ended 2024-12-31		$259.19M
Ended 2024-12-31		$228.53M
Ended 2025-06-30		$130.13M
Ended 2024-12-31
2 years earlier$8.78M
Ended 2023-12-31		$288.94M
Ended 2023-12-31		$200.16M
Ended 2024-06-30		$77.43M
Ended 2023-12-31
3 years earlier$12.40M
Ended 2022-12-31		$883.00M
Ended 2022-12-31		$213.40M
Ended 2023-06-30		$23.64M
Ended 2022-12-31
4 years earliern/a$799.24M
Ended 2021-12-31		$206.36M
Ended 2022-06-30		$3.15M
Ended 2021-12-31